These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 8899087)

  • 1. A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: a pilot study.
    Bernstein CN; Seeger LL; Anton PA; Artinian L; Geffrey S; Goodman W; Belin TR; Shanahan F
    Aliment Pharmacol Ther; 1996 Oct; 10(5):777-86. PubMed ID: 8899087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoporosis in inflammatory bowel disease: effect of calcium and vitamin D with or without fluoride.
    Abitbol V; Mary JY; Roux C; Soulé JC; Belaiche J; Dupas JL; Gendre JP; Lerebours E; Chaussade S;
    Aliment Pharmacol Ther; 2002 May; 16(5):919-27. PubMed ID: 11966500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of relationship of calcium and vitamin D intake to bone mineral density in premenopausal women with inflammatory bowel disease.
    Bernstein CN; Bector S; Leslie WD
    Am J Gastroenterol; 2003 Nov; 98(11):2468-73. PubMed ID: 14638350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 4-year treatment with once-weekly clodronate on prevention of corticosteroid-induced bone loss and fractures in patients with arthritis: evaluation with dual-energy X-ray absorptiometry and quantitative ultrasound.
    Frediani B; Falsetti P; Baldi F; Acciai C; Filippou G; Marcolongo R
    Bone; 2003 Oct; 33(4):575-81. PubMed ID: 14555261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled trial of salmon calcitonin to prevent bone loss in corticosteroid-treated temporal arteritis and polymyalgia rheumatica.
    Healey JH; Paget SA; Williams-Russo P; Szatrowski TP; Schneider R; Spiera H; Mitnick H; Ales K; Schwartzberg P
    Calcif Tissue Int; 1996 Feb; 58(2):73-80. PubMed ID: 8998681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of supplementation of calcium and vitamin D on bone mineral density and bone mineral content in peri- and post-menopause women; a double-blind, randomized, controlled trial.
    Di Daniele N; Carbonelli MG; Candeloro N; Iacopino L; De Lorenzo A; Andreoli A
    Pharmacol Res; 2004 Dec; 50(6):637-41. PubMed ID: 15501704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
    Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
    Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double blind placebo controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long-term oral corticosteroid treatment.
    Pitt P; Li F; Todd P; Webber D; Pack S; Moniz C
    Thorax; 1998 May; 53(5):351-6. PubMed ID: 9708225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis. A prospective, controlled pilot study.
    Wolfhagen FH; van Buuren HR; den Ouden JW; Hop WC; van Leeuwen JP; Schalm SW; Pols HA
    J Hepatol; 1997 Feb; 26(2):325-30. PubMed ID: 9059953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind placebo-controlled study of intravenous clodronate for prevention of steroid-induced bone loss in inflammatory bowel disease.
    Abitbol V; Briot K; Roux C; Roy C; Seksik P; Charachon A; Bouhnik Y; Coffin B; Allez M; Lamarque D; Chaussade S
    Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1184-9. PubMed ID: 17683996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of effect of cyclical etidronate in the prevention of corticosteroid-induced bone loss. Ciblos Study Group.
    Roux C; Oriente P; Laan R; Hughes RA; Ittner J; Goemaere S; Di Munno O; Pouillès JM; Horlait S; Cortet B
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1128-33. PubMed ID: 9543129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: Osteoporosis and inflammatory bowel disease.
    Bernstein CN; Leslie WD
    Aliment Pharmacol Ther; 2004 May; 19(9):941-52. PubMed ID: 15113361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis.
    Struys A; Snelder AA; Mulder H
    Am J Med; 1995 Sep; 99(3):235-42. PubMed ID: 7653482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind placebo-controlled study of the effects of the bisphosphonate risedronate on bone mass in patients with inflammatory bowel disease.
    Henderson S; Hoffman N; Prince R
    Am J Gastroenterol; 2006 Jan; 101(1):119-23. PubMed ID: 16405543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.
    Lems WF; Lodder MC; Lips P; Bijlsma JW; Geusens P; Schrameijer N; van de Ven CM; Dijkmans BA
    Osteoporos Int; 2006; 17(5):716-23. PubMed ID: 16463007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone turnover and density in obese premenopausal women during moderate weight loss and calcium supplementation.
    Shapses SA; Von Thun NL; Heymsfield SB; Ricci TA; Ospina M; Pierson RN; Stahl T
    J Bone Miner Res; 2001 Jul; 16(7):1329-36. PubMed ID: 11450709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and harms of nasal calcitonin in improving bone density in young patients with inflammatory bowel disease: a randomized, placebo-controlled, double-blind trial.
    Pappa HM; Saslowsky TM; Filip-Dhima R; DiFabio D; Hassani Lahsinoui H; Akkad A; Grand RJ; Gordon CM
    Am J Gastroenterol; 2011 Aug; 106(8):1527-43. PubMed ID: 21519359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Milk Powder Supplementation with Different Calcium Contents on Bone Mineral Density of Postmenopausal Women in Northern China: A Randomized Controlled Double-Blind Trial.
    Chen Y; Xiao Y; Xie B; Zhang Q; Ma X; Li N; Liu M; Zhang Q
    Calcif Tissue Int; 2016 Jan; 98(1):60-6. PubMed ID: 26438518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risedronate improves bone mineral density in Crohn's disease: a two year randomized controlled clinical trial.
    Soo I; Siffledeen J; Siminoski K; McQueen B; Fedorak RN
    J Crohns Colitis; 2012 Aug; 6(7):777-86. PubMed ID: 22398088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis.
    Bernstein CN; Seeger LL; Sayre JW; Anton PA; Artinian L; Shanahan F
    J Bone Miner Res; 1995 Feb; 10(2):250-6. PubMed ID: 7754804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.